US 9399774
Modulation of transthyretin expression
granted A61KA61K31/712A61P
Quick answer
US patent 9399774 (Modulation of transthyretin expression) held by Ionis Pharmaceuticals, Inc. expires Mon Jul 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Jul 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 40
- CPC classes
- A61K, A61K31/712, A61P, A61P1/08, A61P1/10